Ret enzyme may be a novel therapeutic target in selected groups of breast cancer pati

[News]

Scientists at the MedUni Vienna, in collaboration with a working group led by Nancy Hynes at the University of Basel, have discovered a new approach in the treatment of breast cancer: an international team involving the Clinical Institute of Pathology at the MedUni Vienna has been able to demonstrate the activation of a receptor, the Ret protein (Rearranged during transfection), on the surface of breast cancer cells. Increased levels of this protein are associated with a lower likelihood of survival for breast cancer patients.

More... (http://www.news-medical.net/news/20130808/Ret-enzyme-may-be-a-novel-therapeutic-target-in-selected-groups-of-breast-cancer-patients.aspx)